China and the United States concluded their 11th bilateral anti-drug intelligence exchange meeting this week, marking a renewed commitment to combating transnational narcotics threats. Held from February 10 to 12 in the U.S., the talks brought together cross-departmental delegations to address evolving challenges in drug control.
Key discussions focused on real-time intelligence sharing, removal of illicit online drug-related content, and joint investigations targeting synthetic drug networks. Both sides also explored enhanced chemical precursor monitoring and anti-money laundering strategies to disrupt trafficking finances.
A Ministry of Public Security spokesperson stated: "This mechanism, active since 2002, demonstrates our shared responsibility in global drug control. Through equal dialogue, we're developing more targeted approaches to protect people in both nations."
The meeting yielded concrete plans for operational coordination in 2026, particularly addressing new psychoactive substances and dark web marketplaces. Analysts note this cooperation gains significance amid shifting drug trade patterns across Asia-Pacific routes.
